1. Home
  2. PHGE vs OMH Comparison

PHGE vs OMH Comparison

Compare PHGE & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • OMH
  • Stock Information
  • Founded
  • PHGE 2015
  • OMH 2015
  • Country
  • PHGE Israel
  • OMH Singapore
  • Employees
  • PHGE N/A
  • OMH N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • PHGE Health Care
  • OMH Finance
  • Exchange
  • PHGE Nasdaq
  • OMH Nasdaq
  • Market Cap
  • PHGE 11.0M
  • OMH 13.6M
  • IPO Year
  • PHGE N/A
  • OMH 2023
  • Fundamental
  • Price
  • PHGE $0.44
  • OMH $1.36
  • Analyst Decision
  • PHGE Strong Buy
  • OMH Hold
  • Analyst Count
  • PHGE 1
  • OMH 1
  • Target Price
  • PHGE $15.00
  • OMH N/A
  • AVG Volume (30 Days)
  • PHGE 284.6K
  • OMH 5.5M
  • Earning Date
  • PHGE 08-13-2025
  • OMH 07-11-2025
  • Dividend Yield
  • PHGE N/A
  • OMH N/A
  • EPS Growth
  • PHGE N/A
  • OMH N/A
  • EPS
  • PHGE N/A
  • OMH N/A
  • Revenue
  • PHGE N/A
  • OMH $7,976,578.00
  • Revenue This Year
  • PHGE N/A
  • OMH $28.40
  • Revenue Next Year
  • PHGE N/A
  • OMH $23.07
  • P/E Ratio
  • PHGE N/A
  • OMH N/A
  • Revenue Growth
  • PHGE N/A
  • OMH 117.53
  • 52 Week Low
  • PHGE $0.34
  • OMH $0.59
  • 52 Week High
  • PHGE $3.86
  • OMH $6.20
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 43.34
  • OMH 42.92
  • Support Level
  • PHGE $0.43
  • OMH $1.35
  • Resistance Level
  • PHGE $0.48
  • OMH $1.58
  • Average True Range (ATR)
  • PHGE 0.05
  • OMH 0.13
  • MACD
  • PHGE 0.00
  • OMH 0.01
  • Stochastic Oscillator
  • PHGE 58.82
  • OMH 10.41

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: